University of Milan at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Milan takes part in 2 sessions at ASH 2026 in New Orleans. Its program centres on myelofibrosis and on blood vessel injury after allogeneic stem cell transplant. It covers where myelofibrosis care is heading and the role of complement in TA-TMA after transplant.
| Organization | ASH 2026 Attendance |
|---|---|
University of Milan Milan, Italy | |
Public research university in Milan, Italy, with a large medical faculty. | Symposium Fri Dec 11 3:00pm–6:00pm A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies. Symposium Fri Dec 11 7:00pm–10:00pm Cases and Conversations™: Endothelial Injury, Complement, and TA-TMA After Allogeneic Stem Cell Transplant Picking graft sources such as expanded cord blood, and treating transplant-associated thrombotic microangiopathy with a newly approved complement inhibitor. |
Instantly find 20 buyers from University of Milan
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction